Data Insights

Muzastotug by Adagene Suzhou for Cervical Cancer: Likelihood of Approval

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Muzastotug in Cervical Cancer

Data Insights

Muzastotug by Adagene Suzhou for Endometrial Cancer: Likelihood of Approval

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Muzastotug in Endometrial Cancer

Data Insights

Muzastotug by Adagene Suzhou for Anal Cancer: Likelihood of Approval

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Anal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Muzastotug in Anal Cancer

Data Insights

Muzastotug by Adagene Suzhou for Penile Cancer: Likelihood of Approval

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Penile Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Muzastotug in Penile Cancer

Data Insights

Muzastotug by Adagene Suzhou for Non-Small Cell Lung Cancer: Likelihood of Approval

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Non-Small Cell Lung Cancer. According to...

Likelihood of Approval and Phase Transition Success Rate Model - Muzastotug in Non-Small Cell Lung Cancer

Data Insights

Muzastotug by Adagene Suzhou for Metastatic Colorectal Cancer: Likelihood of Approval

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Muzastotug in Metastatic Colorectal Cancer